Lou Hawthorne is the CEO of NaNotics LLC, and holds 10 patents for an immune-modulating subtractive nanoparticle for treating cancer and other diseases. He graduated from Princeton in 1983 with a degree in creative writing.
Subscribe to our free weekly newsletter.
